Eli Lilly and Company
American pharmaceutical company
At a glance
Financials
Figures as published in open data for the period shown. They are not live and are not investment advice.
- Revenue
- USD 65.2 billionas of FY2025 (to 2025-12-31)SEC EDGAR 10-K
- Net income
- USD 20.6 billionas of FY2025 (to 2025-12-31)SEC EDGAR 10-K
- Market capitalisation
- USD 713 billionas of 2025-05-01Wikidata
Not covered yet
Business model, products, competitors, market trends and news are still being researched for this profile. We publish them only with named sources, never as unsourced summaries.
Also profiled in Pharmaceuticals
Companies in the same industry. Listing here does not mean they compete directly.

